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Abstract: Curcumin is a bioactive constituent isolated from turmeric that has historically been used as
a seasoning, pigment, and herbal medicine in food. Recently, it has become one of the most commonly
studied nutraceuticals in the pharmaceutical, supplement, and food areas because of its myriad
of potential health benefits. For instance, it is claimed to exhibit antioxidant, anti-inflammatory,
antimicrobial, antiparasite, and anticancer activities when ingested as a drug, supplement, or food.
Toxicity studies suggest that it is safe to consume, even at relatively high levels. Its broad-spectrum
biological activities and low toxicity have meant that it has been widely explored as a nutraceutical
ingredient for application in functional foods. However, there are several hurdles that formulators
must overcome when incorporating curcumin into commercial products, such as its low water
solubility (especially under acidic and neutral conditions), chemical instability (especially under
neutral and alkaline conditions), rapid metabolism by enzymes in the human body, and limited
bioavailability. As a result, only a small fraction of ingested curcumin is actually absorbed into the
bloodstream. These hurdles can be at least partially overcome by using encapsulation technologies,
which involve trapping the curcumin within small particles. Some of the most commonly used edible
microparticles or nanoparticles utilized for this purpose are micelles, liposomes, emulsions, solid lipid
particles, and biopolymer particles. Each of these encapsulation technologies has its own benefits and
limitations for particular product applications and it is important to select the most appropriate one.
Keywords: nanoliposomes; nanoemulsions; solid lipid nanoparticles; microgels; curcumin; functional foods
1. Introduction
Curcumin is a photochemical derived from turmeric, which is a perennial herb belonging to the
Zingiberaceae family. Colloquially, turmeric is referred to as the “golden spice” because of its unique
golden yellow color and earthy pungent flavor [1,2]. In the south and southeast Asian countries,
turmeric has been used as a spice and pigment in food preparations for thousands of years. In addition,
it has been widely used as an herbal medicine due to its perceived therapeutic benefits. Chemically,
there are three major polyphenol substances that belong to the “curcuminoid” family: Curcumin
(diferuloylmethane), demethoxycurcumin, and bisdemethoxycurcumin. Of these, the curcumin form
is the most biologically active, and so it has been the focus in the development of pharmaceutical,
supplement, and food products [3,4].
In functional food applications, curcumin can be considered as a natural ingredient that provides
a distinctive color and flavor profile, as well as having potential health benefits [1,2,4]. Research
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in various fields has shown that the ingestion of curcumin may be beneficial to health due to its
wide range of biological activities, including anti-inflammatory [5,6], antioxidant [6,7], antibacterial,
antiviral, antifungal [8,9], antidiabetic, antitumor, and anticancer [3,10,11] activities. In cases where it
is efficacious, curcumin may have advantages for the prevention or treatment of diseases because of its
low cost, good safety profile, and lack of side effects. The research highlighting the potential benefits of
curcumin has led to it being applied in a variety of commercial food and non-food products, including
energy drinks, supplements, ointments, soaps, and cosmetics [12].
Pure curcumin is an orangey-yellow-colored crystalline material, which normally comes in a
powdered form. Moreover, it is a chemically labile hydrophobic substance that has a low water solubility
(particularly under acidic or neutral conditions, where it is fully protonated), poor chemical stability
(especially under alkaline conditions), and low bioavailability (mainly due to low bioaccessibility
and chemical transformation due to metabolic enzymes in the gastrointestinal tract). In addition,
curcumin is susceptible to chemical degradation during storage, particularly when exposed to light,
high temperatures, and alkaline conditions [13]. Although curcumin is relatively stable to chemical
degradation under acidic conditions, it has a very low water solubility under these conditions,
which can promote crystallization and sedimentation in aqueous delivery systems [14]. For this reason,
it is important to develop effective approaches to overcome these hurdles so that curcumin can be
successfully incorporated into pharmaceuticals, supplements, and functional food products.
One of the most effective means of protecting curcumin against chemical degradation,
increasing its water dispersibility, and improving its bioavailability is to use modern encapsulation
technologies [15,16]. These technologies involve incorporating the curcumin into edible nanoparticles
or microparticles that can then be introduced into food or supplement products [17]. These colloidal
particles are assembled from food-grade ingredients, such as surfactants, phospholipids, lipids, proteins,
polysaccharides, and minerals, using either spontaneous or directed processes. Numerous kinds
of colloidal particles can be employed for this purpose, including micellar aggregates, liposomes,
emulsion droplets, solid lipid particles, and biopolymer particles [18].
2. Chemistry of Curcumin
Curcumin (C21H20O6) is an asymmetric molecule with a molar mass of 368.38 g/mol (Figure 1).
Structurally, it contains three main functional groups: Two aromatic ring systems containing o-methoxy
phenolic groups, and one alpha beta-unsaturated beta-diketone moiety. In aqueous solutions, curcumin
undergoes keto-enol tautomerism with its structure depending on pH: The keto form dominates
under acidic and/or neutral conditions, while the enolate form dominates under alkaline conditions
(Figure 2) [19–21]. The enol form is more chemically labile than the keto form, accounting for the poor
chemical stability of curcumin in basic solutions [21].
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3. Biological Activities of Curcumin
3.1. Antioxidant Activity
One of the main reason that curcu is used in many food formulations is due to its relatively
strong antioxidant activity, which is believed to increase the shelf life of food products and protect cells
from free radical-induced damage. Reactive oxygen species (ROS) generated inside the human body can
promote the oxidation of lipids, proteins, and DNA molecules that place critical roles in normal cellular
function. A number of chr i dise es hav b en linked to this phenomenon, i cluding inflammation,
cardiovascular disease, diabetes, and cancer [6,22,23]. Curcumin exhibits its antioxidant activity by acting
as a free radical scavenger, singlet oxygen quencher, and chelating agent. For instance, it can donate a
hydrogen at m from it β-diketone moiety to lipid alkyl or lipid peroxyl radical , thereby reducing their
activity [24,25]. In addition, it can chelate ferric (Fe2+) an ferrous (Fe2+) ions, which are known to be
potent pro-oxidants. Some studies have also shown that it is highly effective at inhibiting the oxidation
of emulsified lipids. For instance, in linoleic acid emulsions (droplet size not specified), a lower dose of
curcumin (15 µg/mL or 20 mM) was required to inhibit lipid oxidation than butylated hydroxyanisole
(123 mM), butylated hydroxytoluene (102 mM), tocopherol (51 mM), and trolox (90 mM) [7].
3.2. Anti-Inflammatory Activity
Curcumin is also widely used as a nutraceutical in functional foods because of its relatively
strong anti-inflammatory activities. In particular, it has been reported that curcumin can suppress
inflammatory response enzymes and transcription factors, such as TNF-a, IL-1, IL-6, IL8, IL12, monocyte
chemoattractant protein (MCP)-1, cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS),
and lipoxygenase, thereby inhibiting the production of inflammatory cytokines [26,27]. The efficacy of
curcumin for treating rheumatoid arthritis (a disease linked to inflammation of the joints) was compared
to that of a widely used drug for this purpose (diclofenac sodium). After eight weeks, patients reported
that curcumin formulation was more effective at reducing pain, swelling, and tenderness than the drug
and that it exhibited less side effects. Moreover, the patients receiving the drug reported itching and
swelling around their eyes, as well as dimness of vision [28]. Animal studies have also reported that
curcumin reduced inflammation and bone erosion of collagen-induced arthritis (CIA) in rats after eight
weeks of treatment (110 mg/kg) [29]. Other researchers have also claimed that the anti-inflammatory
activity of curcumin is responsible for its ability to inhibit tumor formation and cancer.
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3.3. Antimicrobial Effects
The antimicrobial activity of curcumin means that it has potential to inhibit food spoilage, thereby
prolonging shelf life, as well as deactivating pathogenic organisms, thereby increasing food safety [30].
Moreover, the ingestion of curcumin-rich foods has the potential to treat or prevent some infectious
diseases [31]. Several mechanisms of action have been proposed for the antimicrobial activity of
curcumin, including its ability to increase the permeability of bacterial cell walls, inhibit microtubule
formation, impair bacterial virulence factors, and interfere with key biochemical pathways [32].
For instance, studies have shown that there is an increase in cell membrane leakage for both
Gram-negative (S. aureus and E. faecalis) and Gram-positive (E. coli and P. aeruginosa) bacteria after
being treated with curcumin [33].
3.4. Anticancer
Curcumin has also been reported to have the ability to inhibit the growth of cancer cells by
suppression of angiogenesis and induction of apoptosis [34,35]. In vitro and in vivo studies suggest
that curcumin may be able to downregulate cell growth and proliferation in various types of cancer
cells, including prostate, breast, and colon cancers [34]. In the case of prostate cancer, curcumin
downregulated cancer cell proliferation by attacking epidermal growth factor receptors [36]. Curcumin
has also been shown to suppress cell motility and metastasis by inhibition of bone metastatic
LNCaP-derivative C4-2B prostate cancer cells [36,37]. In the case of breast cancer, curcumin has
been reported to mediate breast cancer cell apoptosis via suppression of NFκB, cyclinD, and MMP-1
expression [38]. In the case of colon cancer, curcumin had been reported to reduce miR-21 promoter
activity and expression by inhibiting HCT116 cells and Rko cells in the G2/M phase, which regulates
progression and metastasis of cancer cells [39,40]. In general, studies have identified multiple signaling
pathways that curcumin can modulate to produce anticancer effects, which often involve the targeting
of multiple key components within these pathways [41]. A summary of a number of molecular targets
of curcumin associated with its anticancer activity is given in Figure 3. It should be noted that other
molecular targets have been identified for other diseases that curcumin can prevent or treat [42].
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activator of transcription 3; WT1: Wilms’ tumor 1 (adapted from Kunnumakkara, 2017).
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4. Potential Toxicity
The potential toxicity and side effects of ingesting curcumin have been investigated for decades
using both animal and human models. A human feeding study reported no toxicity when up to 8 g of
curcumin were ingested every day for three months; however, some of the test subjects did report
minor side effects, such as diarrhea or nausea [43]. Another human study reported only minor side
effects (diarrhea, rash, headache, and yellow stool) in one subject when they were fed relatively high
levels (1–12 g per day) of curcumin for prolonged periods [44]. After reviewing the available evidence,
the United States Food and Drug Admission considers curcumin to be generally regarded as safe [45].
The United Nations and World Health Organization Expert Committee on Food Additives, as well as
the European Food Safety Authority, allow a relatively high daily intake of curcumin: 0 to 3 mg/kg body
weight/day [46,47], which corresponds to up to about 210 mg day for an average person. This level
is well above that reported to have beneficial health effects in human feeding studies [48]. However,
a recent cell culture model showed that curcumin could exhibit beneficial anticancer effects at lower
doses but exhibit toxicity at relatively high doses [49]. These results suggest that it is important to
consider both the dose and bioavailability of the curcumin in specific formulations.
5. Factors Affecting Curcumin’s Application
In this section, some of the main challenges that need to be addressed when formulating
curcumin-based functional foods are discussed.
5.1. Solubility
At room temperature, pure curcumin is a crystalline material with a melting point around 183 ◦C.
In addition, it is a predominantly hydrophobic substance due to the non-polar regions in the aliphatic
bridge, aromatic rings, and methyl groups (Figure 1) [50]. Nevertheless, it does have three hydroxyl
groups, which become deprotonated at sufficiently high pH values, thereby giving it a negative charge
(Figure 2). Consequently, curcumin is a predominantly hydrophobic molecule with low water solubility
under acidic and neutral conditions (where the hydroxyl groups are protonated), but a hydrophilic
molecule with a relatively high water solubility under alkaline conditions (where the hydroxyl groups
are deprotonated) [51]. In particular, the solubility of curcumin increases as the solution pH is raised
around and above the pKa values of the three hydroxyl groups (8.38, 9.88, and 10.51), which are located
in the enolic (pKa:8.38) and phenolic regions (pKa: 9.88 and 10.51) of the molecule (Figures 1 and 2) [52].
For example, below about pH 8, the net charge = 0, the log D = 4.1, and the water solubility are very
low (around 24 mg mL−1 or 0.0024%). Conversely, at pH ≥ 12.0, the net charge = −3, the log D = −2.0,
and the water solubility are very high (> 3 g mL−1). As well as leading to an increase in water solubility
under alkaline conditions, deprotonation of these hydroxyl groups also promotes a color change and
an increase in chemical instability (see the following sections). In most foods, the pH ranges from
about 2 to 8, so that the curcumin is a predominantly hydrophobic molecule with low water solubility.
As a result, it typically needs to be dissolved in some form of hydrophobic substance before it can be
incorporated into aqueous-based foods; otherwise, it will be in a crystalline form. Having said that,
the pH-dependence of the water-solubility of curcumin can be utilized in the formation of colloidal
forms of curcumin, e.g., in the pH-shift method (see later).
5.2. pH-Induced Color Changes
The color of curcumin solutions depends on the protonation state of the three hydroxyl groups
and therefore changes with pH (Figure 2). From pH 2 to 7, all of the hydroxyl groups are protonated,
and the curcumin appears golden yellow, which is the case in most foods. From pH 7 to 8.5, the enolic
hydroxyl group becomes progressively deprotonated, causing the curcumin to change to a more
brownish-orangey color. At still higher pH values, the other two phenolic hydroxyl groups become
deprotonated, causing the curcumin to have a more reddish color [4,13,53]. The chemical state of
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curcumin under specific solution conditions can therefore be elucidated by measuring the UV-visible
absorption spectrum [4]. It should be noted that curcumin chemically degrades under alkaline
conditions, which causes changes in its color.
5.3. Chemical Degradation
5.3.1. Alkaline Degradation
As mentioned earlier, the water solubility of curcumin increases under alkaline conditions,
which contributes to an increased rate of chemical decomposition. At pH values around and above
the pKa values of its hydroxyl groups, curcumin undergoes rapid hydrolytic degradation, which has
been attributed to cleavage of the α, β-unsaturated β-diketone moiety. As a result, the original
curcumin molecule is transformed into trans-6-(4′-hydroxy-3′-methoxyphenyl)-2,4-dioxo-5-hexanal,
which itself undergoes cleavage reactions to form ferulic acid, feruloylmethane, and vanillin [4,13,53,54]
(Figure 2). The color of curcumin fades due to this alkaline degradation reaction. In phosphate buffer
solutions, it has been reported that around 90% of curcumin degraded within 15 min of incubation
at neutral or alkali conditions, but the molecule was relatively resistant to degradation under acidic
conditions [14,55]. The possible degradation of curcumin under neutral and alkaline conditions must
therefore be considered when developing curcumin-enriched functional foods.
5.3.2. Photodegradation
Curcumin (crystalline or solubilized) also undergoes chemical degradation when exposed to
light, which promotes color fading [56,57]. The photodegradation of curcumin is also initiated
at the α, β-unsaturated β-diketone moiety and leads to a variety of reaction products, including
p-hydroxybenzaldehyde, vanillin, vanilic acid, ferulic aldehyde, and ferulic acid (Figure 2) [56].
Typically, the crystalline form of curcumin is more stable to photodegradation than the solubilized
form, which may be because a higher fraction of the light waves is able to penetrate into a clear solution.
Certain reaction products (e.g., vanillin and ferulic acid) have been reported to have some antioxidant
and anticancer activities, but they are less potent than the curcumin molecule itself [58–60].
5.3.3. Autoxidation
Curcumin may also chemically degrade due to autoxidation reactions that occur spontaneously
in aqueous solutions via a radical chain reaction [61,62]. Initially, free radicals in the surrounding
solution initiate autoxidation of the phenolic hydroxyls on the curcumin molecule, which results in
the formation of an unstable intermediate that breaks down through a series of reactions to form
bicyclopentadione [61,63]. This reaction product has been shown to exhibit some anticancer activity
but less than that of curcumin itself [63,64].
5.4. Bioavailability
In this section, some of the main factors limiting the bioavailability of curcumin are highlighted
(Figure 4).
5.4.1. Bioaccessibility, Chemical Transformation, and Absorption
The high melting point and low water solubility of curcumin under acidic and neutral conditions
mean that pure curcumin crystals typically have a low bioaccessibility. In other words, the crystals do
not readily dissolve in the aqueous gastrointestinal fluids, which reduces their ability to be transported
through the mucus layer and be absorbed by the epithelium cells [34,65]. The bioavailability of curcumin
may also be limited due to chemical transformation within the gastrointestinal tract. Curcumin is
resistant to degradation under acidic environments, and should therefore remain stable in the stomach.
Conversely, it is prone to alkaline degradation under neutral or basic conditions and so may be
unstable in the small intestine and colon. Some studies have shown that curcumin may also undergo
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autoxidation under physiological pH conditions [3]. Despite these potential degradation mechanisms,
a rat study reported that around 90% of ingested curcumin remained in the gastrointestinal tract
(GIT) after exposure to the stomach and small intestine conditions for 30 min, suggesting that its
degradation was relatively slow within the gut [66]. The bioaccessibility and chemical stability of
curcumin can be increased by encapsulating it within a lipid phase, such as a bulk or emulsified
oil [50,67]. Trapping the curcumin within a lipid phase protects it from chemical degradation by
physically isolating it from reactants in the aqueous gastrointestinal fluids. Moreover, the utilization
of a digestible lipid phase (such as a triglyceride) leads to the production of lipid digestion products
(fatty acids and monoglycerides) that are incorporated into mixed micelles. These mixed micelles can
then solubilize the curcumin within their hydrophobic interiors, thereby enhancing its bioaccessibility.
Moreover, they can transport the hydrophobic curcumin molecules to the epithelium cells where they
can be absorbed. After absorption, the curcumin may be metabolized within the epithelium cells
and/or expelled back into the intestinal lumen due to the presence of efflux transporters within the
cell membranes [68,69]. Some substances within foods, such as piperine in black pepper and certain
catechins in green tea, are able to inhibit these efflux transporters, therefore increasing the amount
of curcumin remaining in the body [70,71]. This gives food formulators an approach to increase the
potential bioactivity of curcumin using common food ingredients that act as efflux inhibitors [72].
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5.4.2. Metabolism
One of the main reasons for the poor oral bioavailability of curcumin is its rapid metabolism
by metabolic enzymes inside the gut, as well as after absorption (particularly in the liver),
leading to the formation of a variety of metabolites with different biological activities to the
parent molecule [65]. The human intestine and liver contain phenol sulfotransferase isoenzymes
that convert curcumin into curcumin sulfates, as well as glucuronidases that convert curcumin
into curcumin glucuronides [73]. In addition, a number of other metabolites may be formed,
including bicyclopentadione, dihydrocurcumin, tetrahydrocurcumin (THC), hexahydrocurcumin
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(HHC), octahydrocurcumin (OHC), hexahydrocurcuminol, dihydroferulic acid, and ferulic acid [72,74].
The majority of the curcumin glucuronides, curcumin sulfates, and other metabolites are fairly water
soluble and so are quickly excreted from the body via the urine and feces [75,76]
A number of the metabolites of curcumin have been found to exhibit some biological activity.
THC has been reported to have stronger anti-inflammatory, antidiabetic, and antihyperlipidemic activity
than curcumin, as well as a similar antioxidant activity [22,58,77]. HHC has been reported to have
similar or better antioxidant, anti-inflammatory, anticancer, and cardiovascular protective activities as
curcumin [78–80]. OHC has also been reported to have superior anticancer properties than curcumin,
by being more effective at suppressing tumor growth and inducing cancer cell apoptosis [81,82].
In contrast, curcumin glucuronide has been reported to have a lower absorption and anticancer activity
than curcumin [83]. Curcumin glucuronides and curcumin sulfates have also been reported to be less
bioactive than other metabolites, as well as the parent molecule [84].
5.4.3. Tissue Distribution
After absorption, curcumin enters the bloodstream and is rapidly distributed throughout the
body, resulting in it being located in many tissues at detectable levels, including the liver, kidney, colon,
brain, heart, lung, and spleen [66,72,85–87]. For instance, a rat study reported that a small amount
of curcumin was found in the liver and kidney soon after oral administration, while about 38% was
present in the large intestine after 24 h [66]. The maximum curcumin concentration was detected in the
liver (around 45 µg/whole tissue) and kidney (6 µg/whole tissue) after 3 h. The amount of curcumin in
the kidney has been reported to decline after about 24 h, while that in the liver remains fairly constant
for up to 4 days [86]. A rat feeding study reported that different levels of curcumin were detected in
different tissues after oral administration: Liver (70 nmol/mL), kidney (78 µmol/mL), brain (3 nmol/mL),
lung (15 nmol/mL), heart (9 nmol/mL), and muscle tissue (8 nmol/mL) [85]. These results suggest that
curcumin has the potential to work in various tissues within the human body, which means that it may
be able to treat a variety of different disease conditions.
5.4.4. Elimination
Curcumin is eliminated from the body more through the feces than through the urine, which may
be due to its relatively low water solubility [87]. An animal study suggested that about 34% of curcumin
was excreted through the feces, while less than 0.2% was secreted in the urine [86]. Nevertheless,
curcumin metabolites (such as glucuronides and sulfates), which are much more water soluble than
the parent molecule, tend to be excreted through both the urine and feces [75,76].
5.4.5. Pharmacokinetics
Pharmacokinetic studies have been used to study the levels of curcumin in the bloodstream of
animals and humans after oral ingestion. These studies typically show that the fraction of curcumin
reaching the bloodstream in an intact form is very low. For instance, in an animal study, it was
reported that there was only about 0.22 µg/mL of curcumin in blood samples taken an hour after
oral administration of 1.0 g curcumin per kg body weight, with this concentration declining over the
following 6 h [88]. In a human trial, only around 11 nmol/L curcumin was detected in blood plasma
collected an hour after oral administration of 3.6 g of curcumin [76]. In human feeding studies, even a
relatively high intake of curcumin (8 g per day) led to a relatively low serum level (2 µm/mL) in blood
samples collected an hour or two after consumption [43]. These studies indicate that only a very small
fraction of ingested curcumin actually gets into the systemic circulation in humans, which may limit its
potential biological activity.
6. Strategies to Overcome the Challenges of Curcumin
Potential strategies to improve the solubility/dispersibility, stability, and bioavailability of curcumin
are highlighted in this section.
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6.1. Methods to Enhance Solubility/Dispersibility of Curcumin
The solubility of curcumin in both oil and water phases is important when developing effective
formulations to encapsulate and deliver it. At room temperature, pure curcumin is typically in a
powdered crystalline form. Consequently, it must be dissolved or dispersed within an appropriate
solvent before it can be incorporated into a suitable food format. In this section, a number of approaches
for introducing curcumin into solvents are highlighted.
6.1.1. Direct Dissolution
Curcumin has a relatively low water solubility (under neutral or acidic conditions), but it can be
directly dissolved within oils and some organic solvents due to its lipophilic nature. It should also
be noted that curcumin tends to exist in the keto-form in water (under most pH conditions found in
foods) but in the enolic form in oils and organic solvents (Figure 3). Some of the most common organic
solvents used to directly solubilize curcumin are ethanol, methanol, chloroform, acetone, and dimethoxy
sulfoxide [4]. These solvents are often used to dissolve curcumin prior to creating colloidal delivery
systems. For instance, ethanol is often used to solubilize both curcumin and particle-forming materials,
such as surfactants, phospholipids, hydrophobic proteins, or hydrophobic polysaccharides. Colloidal
particles are then formed using an antisolvent precipitation method by injecting the ethanol mixture
into water [89,90]. When the hydrophobic curcumin and particle-forming materials come into contact
with water, curcumin-loaded particles are spontaneously formed. Curcumin has been loaded into zein
nanoparticles using this method [91]. One disadvantage of using organic solvents for this purpose is
that they may be environmentally unfriendly and additional costs are associated with removing and
analyzing them in the final formulation [92,93]. This problem can be overcome by using supercritical
fluids (such as supercritical carbon dioxide) to dissolve the curcumin [94,95]. Alternatively, alkaline
water can be used as a solvent, rather than an organic fluid.
As mentioned earlier, the solubility of curcumin increases substantially when the solution is
raised above about pH 9 because the molecule changes from hydrophobic to hydrophilic (Figure 2).
Consequently, curcumin can be solubilized in highly alkaline solutions. Curcumin-loaded colloidal
particles can then be formed using a pH-shift method that involves injecting the alkaline curcumin
solution into an acidified aqueous colloidal suspension. The pH decreases when these two systems are
mixed together, which causes the curcumin to become more hydrophobic and move into the non-polar
regions within the colloidal particles. This approach has been used to encapsulate curcumin into
surface micelles [96], solid lipid particles, liposomes [97], emulsions, protein nanoparticles [98,99],
and oil bodies [99,100]. The curcumin should only be kept for a relatively short time under highly
alkaline conditions to avoid its degradation.
6.1.2. Mechanical Action
The dissolution of crystalline curcumin in solvents can be increased by applying mechanical
forces, such as stirring and sonication. Sonication is particularly suitable for this purpose because
it generates intense fluctuating pressure waves that induce acoustic cavitation, leading to efficient
mixing and dissolution [101,102].
6.1.3. Heating
The solubility of crystalline materials in solvents usually increases as the temperature is raised.
Consequently, it is possible to solubilize a higher concentration of curcumin by heating the system.
This approach has been used to facilitate the dissolution of powdered curcumin into bulk oils, prior to
emulsion formation [103]. It has also been used to increase the dissolution of powdered curcumin into
pre-existing emulsions [104].
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6.1.4. Encapsulation Technologies
One of the most common approaches to improve the water dispersibility of curcumin is to
incorporate it within colloidal particles that have a hydrophobic interior but a hydrophilic exterior,
such as micelles, microemulsions, emulsions, or hydrophobic biopolymer particles. Numerous kinds
of colloidal particles that can be used for this purpose are covered in more detail in Section 6.3.
6.2. Methods to Enhance Stability of Curcumin
As mentioned earlier, curcumin is susceptible to chemical transformation when exposed to certain
conditions, such as alkaline pH, light, elevated temperatures, transition metals, and metabolic enzymes.
For this reason, it is necessary to develop effective strategies to protect it from chemical degradation so
that it can reach the target organs in an active state.
6.2.1. Antioxidant Technologies
As mentioned in Section 3.1, curcumin can be used in foods as a natural antioxidant. In these
cases, the curcumin is usually chemically transformed, which may alter its biological activity. In many
applications, it is desirable to prevent the chemical degradation of curcumin to maintain its beneficial
biological activities after ingestion. The chemical degradation of curcumin can be inhibited by adding
synthetic or natural antioxidants [105]. These authors reported that co-administration of curcumin
with certain antioxidants decreased the degradation rate and increased the amount absorbed after oral
administration to rats. Specifically, a number of food-grade redox-active antioxidants were shown to
greatly improve curcumin stability, including ascorbic acid, gallic acid, caffeic acid, rosmarinic acid,
tert-butylhydroquinone, and Trolox. The addition of antioxidants has also been shown to enhance the
stability of curcumin encapsulated within oil-in-water emulsions [106]. Hydrophilic and amphiphilic
antioxidants were found to be more effective than lipophilic ones in this study, which may be because
the chemical degradation of curcumin occurs more rapidly in the water phase. Overall, the authors
reported the following order of efficacy for different antioxidants: Trolox ≈ ascorbic acid > ascorbyl
palmitate >> control > alpha-tocopherol. These results suggest that the stability of curcumin in food
formulations can be improved by adding appropriate antioxidants.
6.2.2. Encapsulation Technologies
The chemical degradation of curcumin occurs faster when it is surrounded by water than oil,
because substances that accelerate the degradation reaction (such as hydroxyl ions) are mainly located
within the aqueous phase [14]. Consequently, the stability of curcumin to chemical degradation
can be improved by encapsulating it within a hydrophobic phase, which may be a bulk phase
(such as pure oil) or colloidal particles (such as oil droplets, solid fat particles, or hydrophobic
protein particles) [14,107,108]. Interestingly, the chemical stability of curcumin increases as the size of
these hydrophobic colloidal particles increases, because then there is a slower exchange of curcumin
molecules between the particles and the surrounding aqueous phase [109]. Encapsulation technologies
that utilize colloidal particles to improve the chemical stability and bioavailability of curcumin in
aqueous-based systems are discussed in Section 6.3.
6.2.3. Controlling Environmental Conditions
Curcumin is known to degrade faster when exposed to light [110], high temperatures [14],
high oxygen levels [111], and alkaline environments [14]. It is therefore possible to improve its stability
by controlling the solution, environmental, and/or packaging conditions. For instance, the chemical
stability of curcumin can be improved by incorporating it into acidic products (pH < 7) that are stored
at low temperatures in the dark, e.g., fruit juices, dressings, or some nutritional beverages [50,67].
Alternatively, it may be possible to exclude light and oxygen by using appropriate packaging procedures
and materials, thereby further enhancing the stability of curcumin-based products.
Molecules 2020, 25, 2791 11 of 25
6.3. Methods to Enhance the Bioavailability of Curcumin
The bioavailability of curcumin can be enhanced by retarding its metabolism, increasing its
bioaccessibility, and/or promoting its absorption. The enzymes that metabolize curcumin are located
within the aqueous phase or within the cell membranes inside the human body. Consequently,
the metabolism of curcumin can therefore be inhibited by trapping it inside hydrophobic phases
that isolate it from the enzymes, such as those inside micellar, liposomal, microemulsion, emulsion,
solid fat, or biopolymer particles. The bioaccessibility of curcumin can be increased by enhancing
the amount that is solubilized within the mixed micelles present in the small intestine. This may
be achieved by including surfactants, phospholipids, fatty acids, or monoglycerides within the
curcumin-loaded carrier particles, as these surface-active substances, can become incorporated into
the mixed micelles and increase their solubilization capacity. Alternatively, this can be achieved
by including digestible lipids within the curcumin-loaded carrier particles, such as triglycerides or
diglycerides. These lipids are then converted into monoglycerides and fatty acids by lipase in the human
gut, thereby generating surface-active materials that can be incorporated into the mixed micelles and
enhance their solubilization capacity. Finally, substances that increase the permeability of the epithelium
cell membranes or that block efflux transporters can be incorporated into the curcumin-loaded carrier
particles. For instance, some surfactants, fatty acids, biopolymers, and phytochemicals have been
shown to increase the permeability of epithelium cells, thereby leading to enhanced absorption
of hydrophobic bioactives [112–114]. As mentioned previously, certain kinds of food components,
including piperine in black pepper and some catechins in green tea, can inhibit efflux transporters,
thereby increasing the amount of curcumin absorbed by the body [70,71].
7. Colloidal Delivery Systems
Colloidal delivery systems have been widely explored for their ability to increase the bioavailability
of polyphenols, like curcumin [18]. Numerous kinds of colloidal delivery systems have been
shown to be suitable for this purpose, including micelles, microemulsions, emulsions, solid lipid
nanoparticles, protein nanoparticles, and biopolymer microgels. The curcumin-loaded colloidal
particles can then be incorporated into functional food and beverage systems, or converted into a
powdered form and used in supplements. Many factors impact the selection of a colloidal delivery
system for a particular application: Particle characteristics (composition, size, shape, morphology,
charge, digestibility, stability), loading properties (encapsulation efficiency, loading capacity, retention
efficiency), physicochemical properties (optical properties, rheology, shelf-life), sensory attributes
(flavor profile, mouthfeel), economics (ingredient and manufacturing costs), regulations, and label
friendliness (all natural, vegan, Kosher) [115]. Excipient foods can be used as an alternative strategy
to delivery systems for enhancing the bioavailability of curcumin. An alternative strategy is to use
excipient foods to enhance the bioavailability of curcumin. An excipient is a food that contains no
bioactive components itself but breaks down in the human gut to form an environment that enhances
the bioaccessibility, stability, or absorption of any curcumin co-ingested with it. Emulsified foods
containing digestible lipids are particularly suitable for this purpose, including milk, creams, dressings,
sauces, or yogurts [116]. A schematic diagram of different colloidal delivery systems that can be used
to encapsulate curcumin is shown in Figure 5.
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7.1. Micelles
Micelles have been widely used to improve the solubility and bioavailability of hydrophobic
drug and nutraceuticals [117,118]. They are sp ntaneously formed when surfactants are dispersed
in water above their critical micelle concentrati s. Consequently, they can often be fabricated using
very simple processing methods, such as heating and/or mixing of the bioactive, surfactant, and water
together. After assembly, the hydrophobic tails congregate together in the interior of the micelles,
while the hydrophilic head groups point outwards towards the water. Micelles are typically formed
from synthetic surfactants, but they ca also be formed from certain kinds of natural surfactants,
such as casein [119,120]. Curcumin can be solubilized within the hydrophobic interior of the micelles by
adding it before or after micelle formation. Typically, micelles are relatively thermodynamically stable
colloidal dispersions containing relatively small (ty ically 5 to 20 nm) particles. As a result, they tend to
be optically transparent because the particles are so s all that they do not scatter light waves strongly.
The viscosities of micellar systems depend on the surfactant concentration and micelle structure.
At low concentrations, they tend to be fluids with low viscosities, whereas at higher concentrations,
they tend to be semi-solids with high viscosities or gel-like textures. The rheological properties of
micellar systems depend strongly on the surfactant type and environmental conditions because these
factors influence the size, shape, interactions, and dynamics of the colloidal structures formed [121].
Micelles enhance the bioavailability of hydrophobic compounds (like curcumin) by increasing their
bioaccessibility in the gastrointestinal fluids, as well as possibly increasing the permeability of the
epithelium cells [122].
Synthetic food-grade surfactants, such as Tweens, have been widely used to solubilize
curcumin [123]. The solubilization of curcumin has been reported to increase with increasing
chain length and decreasing the unsaturation of the surfactant tail groups [123]. Natural surfactants,
such as casein, have also been used to solubilize curcumin within aqueous solutions [124], which may
be more suitable for certain food applications. The pharmacokinetics of curcumin-fortified Tween
80 micelles have been tested in a human feeding study. The curcumin–micelle formulation was found
to have a 185-fold higher area under the curve than free curcumin, without exhibiting any adverse
side-effects [125].
Molecules 2020, 25, 2791 13 of 25
7.2. Liposomes
Liposomes are self-assembled spherical particles consisting of one or more phospholipid
bilayers [93,126]. They therefore have a structure that is somewhat similar to biological cell wall
membranes. A phospholipid molecule consists of a hydrophilic head group and a hydrophobic
tail group consisting of two fatty acid chains. In a single bilayer, the phospholipid molecules are
organized tail to tail, therefore forming a thin hydrophobic domain, while the polar head groups face
outwards. Liposomes containing multiple bilayers often have an onion-like structure with concentric
rings of individual bilayers. Liposomes therefore have polar, non-polar, and amphiphilic regions
inside the same colloidal particle, which can be useful for encapsulating one or more bioactive agents
with different polarities within a single delivery system. Liposomes vary greatly in dimensions,
ranging from around 25 nm to 25 µm depending on the formulation and fabrication method used.
Curcumin-loaded liposomes typically have an orangey-yellow clear or slightly turbid look depending
on the particle size [91].
Liposomes can be prepared using various methods, including passive-loading, active-loading,
mechanical-dispersion, solvent-dispersion, and detergent-removal methods [126]. The preparation
method used affects the nature of the liposomes formed, as well as the loading capacity of the curcumin.
The characteristics of curcumin-loaded liposomes prepared using three different methods have been
compared:Thin film, ethanol injection, and pH-driven methods [97]. The initial diameters of the
liposomes decreased in the following trend: Thin film (452 nm) > pH-driven (217 nm) > ethanol
injection (115 nm). The initial encapsulation efficiency of the liposomes for curcumin decreased as
follows: Thin film (78%) > pH-driven (66%) > ethanol injection (39%). The physical and chemical
stability of the curcumin-loaded liposomes also depended on the fabrication methods. After 30 days
of storage in the dark (4 ◦C), the mean particle diameters increased to 1650, 234, and 153 nm for the
thin film, pH-driven, and ethanol injection methods, while the curcumin concentration decreased
by 50%, 2%, and 2%, respectively. The effect of the ionic strength (0.1 to 1 M NaCl) on the stability
of the liposomes was also assessed. Overall, the salt stability of the emulsions decreased as their
initial particle size increased. In particular, the liposomes prepared by ethanol injection (which had
the smallest initial size) were stable to salt addition, with little change in their appearance at any salt
level after storage. Conversely, an increase in turbidity and precipitation were observed in the other
liposome suspensions at high salt levels. Overall, the results suggest that controlling the liposome
size is important for maintaining good product stability [97]. In another study, it was shown that
curcumin-loaded liposomes could inhibit the chemical degradation of curcumin, especially when
exposed to transition metal ions (Fe3+, Fe2+, Al3+, and Cu2+) [127].
The phospholipid source may also influence the physicochemical characteristics of curcumin-
loaded liposomes. One study compared the properties of curcumin-loaded liposomes produced using
a thin film/ultrasonic dispersion method that were fabricated from either milk fat globule membrane
(MFGM) or soybean lecithin [128]. There were differences in the encapsulation efficiency, mean particle
diameter, and ζ-potential of the liposomes depending on the lecithin type: EE = 74%, d = 212 nm
ζ = +7.6 mV for MFGM; EE = 63%, d = 471 nm and ζ=−48.6 mV for soybean lecithin. The encapsulation
of the curcumin was also shown to protect it from degradation when exposed to alkaline conditions,
Fe3+, light, heating, oxygen, and relative humidity, with the MFGM liposomes giving slightly better
protection than the soybean lecithin ones [128]. Other studies have also shown that the lecithin type
influences the encapsulation efficiency and stability of curcumin in liposomes [129].
The impact of liposome encapsulation on the bioavailability of curcumin has been studied using
both in vitro and in vivo experiences. Interestingly, an in vitro gastrointestinal tract study showed
that curcumin in larger liposomes (200 or 450 nm) had a higher bioaccessibility than that in smaller
ones (114 nm) [97]. An animal feeding study was used to investigate the oral bioavailability of
the two curcumin-loaded liposome formulations: Flexible liposomes (FLs) and silica-coated flexible
liposomes (SLs) [130]. Pure curcumin suspended in water was used as a control. The curcumin
concentrations within the blood plasma of the animals were measured up to 12 h after oral administration.
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The maximum curcumin concentration occurred after 45 min for both the FL formulation and the
control, with values of 129 and 71 ng/L, respectively. Conversely, the maximum curcumin concentration
occurred after 3 h for the SL formulation, with a value of 447 ng/L. Moreover, no curcumin was detected
in the plasma of the animals after 4 h for the control, while around 20 ng/L still remained after 12 h for
the encapsulated curcumin. Overall, both the SL (7.8-fold) and FL (2.4-fold) formulations gave a higher
total amount of curcumin within the blood compared to free curcumin [130]. Thus, both liposome
formulations were effective at increasing curcumin bioavailability.
Other researchers have also used an animal model (mice) to study the impact of liposomal
encapsulation of curcumin on its bioavailability [129]. The maximum plasma concentration and time to
reach this value depended on the formulation used: Free curcumin (Cmax = 64 µg/L; Tmax = 120 min);
curcumin-loaded liposomes (Cmax = 319 µg/L; Tmax = 30 min); and free curcumin + liposomes
(Cmax = 78 µg/L; Tmax = 120 min). These results show that the bioavailability can again be increased by
delivering curcumin in the form of liposomes. Importantly, liposomal curcumin also exhibited higher
plasma antioxidation activity than the other two curcumin formulations [129], which can be attributed
to its higher plasma level. Curcumin-loaded liposomes have been shown to exhibit the same cellular
antioxidant activity as free curcumin when exposed to Caco-2 cells for 2 h [127], which shows that
encapsulation did not reduce the bioactivity of this nutraceutical.
7.3. Microemulsions
In general, microemulsions are thermodynamically stable isotropic colloidal dispersions formed
from oil, water, and surfactant. Oil-in-water microemulsions contain small colloidal particles (typically
5 to 50 nm) comprised of oil and surfactant, which have a hydrophobic core and a hydrophilic shell.
Any hydrophobic or amphiphilic bioactive substances can be incorporated into these colloidal particles.
The fact that the colloidal particles in microemulsions are much smaller than the wavelength of light
means that they are typically optically clear or only slightly turbid. Because they are thermodynamically
stable systems, microemulsions should form spontaneously when the different components are mixed
together, but some mechanical mixing and/or heating may be required to facilitate this process.
This is because there may be a kinetic energy barrier between the separated substances and the final
microemulsion system that must be overcome.
Researchers have tried to optimize the formulation of curcumin-loaded microemulsions by varying
the type and level of different substances used to fabricate them. For instance, one study reported that
an optimum formulation consisted of DL-α-tocopherol (3.3 wt%), Tween 20 (53.8 wt%), and ethanol
(6.6 wt%) [131]. This curcumin-loaded microemulsion had a clear yellow appearance, due to its small
particle diameter (5 nm) and high curcumin level (14.6 mg/mL). These curcumin-loaded microemulsions
remained stable when stored under refrigerator conditions (4 ◦C) for a month, with no significant
change in particle size or curcumin concentration. This study also showed that the encapsulated
curcumin had a relatively high permeability (around 70%) when tested using an in vitro method [131].
Another study showed that self-micro-emulsifying drug delivery systems (SMEDDSs) fabricated
from oils and surfactants could be used to encapsulate and release curcumin [132]. In this case,
the curcumin, oil, and surfactant are mixed together and then incorporated into capsules or pellets.
This mixture spontaneously forms a microemulsion when it comes into contact with aqueous
gastrointestinal fluids. These formulations exhibited excellent physical and chemical stability during
storage, as well as leading to a 17-fold increase in the oral bioavailability of the curcumin (compared to
the non-encapsulated form) using animal feeding studies [132]. Similar findings have been reported in
other animal feeding studies using SMEDDSs [133]. Overall, these results suggest that microemulsions
can be designed to encapsulate curcumin, improve its stability, and enhance its bioavailability. For food
applications, however, the potential limitations of this approach are the high levels of synthetic
surfactant required, which can cause problems with cost, taste, and toxicity.
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7.4. Nanoemulsions and Emulsions
Nanoemulsions and emulsions typically consist of two immiscible liquids stabilized by an
emulsifier, and perhaps other ingredients, such as thickening agents, gelling agents, ripening inhibitors,
or weighting agents [134]. Nanoemulsions typically contain droplets with a mean diameter between
about 20 and 200 nm, whereas emulsions contain droplets with mean diameters greater than 200 nm [135].
As a result, nanoemulsions may appear clear to opaque, whereas emulsions nearly always appear
opaque, due to differences in light scattering. Because nanoemulsions have a greater specific surface
area (AS), they need more emulsifier to stabilize them, since AS is proportional to the reciprocal of the
mean particle diameter (d32). The physicochemical principles underlying the formation and stability
of emulsions and nanoemulsions are the same, and so we will simply refer to them as “emulsions” in
the remainder of this section.
For encapsulation purposes, oil-in-water (O/W) emulsions are typically used because hydrophobic
substances can be encapsulated inside the droplets and then introduced into aqueous-based food
and beverage products. The small droplets found in emulsions can be produced using two different
approaches: High- or low-intensity methods [135]. High-intensity methods employ mechanical devices
that apply intense disruptive stresses to fluids, which cause large droplets to break down into smaller
ones, and include high-shearing colloid mills, high-pressure homogenization, microfluidization,
and sonication devices. Low-intensity methods rely on spontaneous droplet formation when
oil–water–surfactant mixtures are exposed to particular conditions (compositions/temperatures),
which includes phase inversion temperature and spontaneous emulsification methods [134,135].
Emulsion-based systems have been widely used for the encapsulation, stabilization, and delivery of
curcumin. Curcumin-loaded emulsions have a yellow-orange clear to milky appearance, depending on
the droplet concentration, droplet size, curcumin concentration, and solution pH [100]. As mentioned
earlier, the emulsions look clear when the droplets are very small (< 40 nm) but milky when they are
larger. The color of the emulsions depends on pH because of changes in the molecular conformation of
the curcumin molecules discussed earlier [136].
Researchers have examined the impact of formulation parameters on the formation and
functionality of curcumin-loaded emulsions, including the oil type, emulsifier type, and curcumin-
solubilization method [137]. In particular, five oils (canola, corn, linseed, medium-chain triglycerides
(MCTs), and sunflower, oil), four emulsifiers (lecithin, Tween 80, gum acacia, and whey protein),
and three solubilization methods (heating, sonication, and microwaving) were investigated. Overall,
heating was the most efficient method of dissolving curcumin in the oil phase, while MCT led
to the highest curcumin content in the oil phase. The synthetic surfactant (Tween 80) produced
curcumin-loaded MCT emulsions with relatively high curcumin contents, small particle diameters,
high surface potentials, and good physical and chemical stabilities [137]. The natural emulsifiers could
also produce curcumin-loaded emulsions, but they were not as stable as the ones produced by the
synthetic surfactant.
Another study compared three methods of producing curcumin-loaded emulsions from all-natural
ingredients (corn oil and quillaja saponin): Conventional, heat-driven, and pH-driven methods.
The conventional method involved dissolving powdered curcumin in an oil phase and then forming an
emulsion by high-pressure homogenization. The heat-driven method involved preparing an emulsion
first, and then heating it in the presence of powdered curcumin (100 C for 15 min). The pH-driven method
involved mixing an acidified emulsion with an alkaline curcumin solution. The encapsulation efficiency
was higher for the pH-driven method (93%) than the heat-driven method (76.2%) or conventional
method (55.5%). The oil droplets in the curcumin-loaded emulsions produced using the pH-driven
method had a high negative charge (−45 mV) and small particle diameter (180 nm). The bioaccessibility
of the curcumin in the emulsions was determined using an in vitro model, and shown to be higher
than non-encapsulated curcumin, as well as commercial curcumin supplements [55].
The physical and chemical stability of curcumin-loaded oil droplets has been shown to depend on
their mean diameter (0.17, 0.52, or 14 µm) [138]. As expected, the rate of droplet creaming increased
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with increasing droplet size because of the increase in gravitational forces. Conversely, the chemical
instability of the curcumin decreased with increasing droplet size, which was attributed to the reduction
in the contact area between the oil and water phases. Overall, curcumin bioaccessibility did not depend
strongly on the droplet size because of the competing effects of increased solubilization but decreased
chemical stability of the curcumin in smaller droplets.
An animal (mouse) study examined the impact of the oil droplet size (50, 100, and 200 nm) on
curcumin bioavailability, anti-inflammatory activity, and antiallergic effects [139]. Interestingly, a higher
maximum plasma concentration and longer time to reach this value were found in the blood for the
100 nm droplets (Cmax ≈ 11 ng/mL, Tmax = 2 h) than for the 50 nm or 200 nm ones (Cmax ≈ 5 ng/mL,
Tmax = 2 h). The 100 nm droplets also exhibited higher anti-inflammatory and antiallergic effects [139].
Again, these effects may be due to conflicting influences of the particle size on the bioaccessibility,
stability, and absorption.
7.5. Solid Lipid Particles
Solid lipid nanoparticles (SLNs) are similar in composition and structure to oil-in-water emulsions,
except that the lipid phase is crystalline at the application temperature [140,141]. The size of the lipid
particles in the SLN suspensions vary from around 20 to 1000 nm depending on the formulation and
preparation method used. Suspensions in the lower particle size range (< 50 nm) appear transparent,
whereas those containing larger particles appear cloudy or opaque [142]. SLNs are typically prepared
using the same methods as emulsions (high-pressure homogenization, sonication, or microfluidization),
except homogenization is usually carried out at a temperature appreciably above the melting point
of the lipid phase. In principle, a solidified lipid core is more effective at retaining and stabilizing
curcumin than a liquified one. However, the system must be carefully designed to inhibit particle
aggregation and curcumin expulsion when the lipid phase crystallizes [140,141]. In addition, solidified
lipid phases are typically digested more slowly than liquid ones, which may lead to prolonged release
of any encapsulated substances.
Curcumin has been successfully encapsulated within SLNs coated by biopolymers (caseinate or
caseinate/pectin) [143]. The size, charge, and stability of these SLNs could be controlled by optimizing
the formulation and preparation methods used. Curcumin has also been encapsulated within SLNs
coated by soy lecithin and Tween 80 [144]. Initially, the SLNs had a relatively small diameter (134 nm)
and a high encapsulation efficiency for curcumin (92%). After incubation for 12 months at a refrigerated
temperature (5 ◦C), the particle size only increased slightly (160 nm) and the curcumin content only
decreased slightly (3%). These results suggest that the SLNs were suitable for curcumin encapsulation
under low-temperature storage conditions. The researchers also investigated the pharmacokinetics of
curcumin after oral administration to rats. Encapsulation of curcumin within the SLNs led to a 48-fold
increase in the plasma concentration and a 39-fold increase in the area under the curve compared to a
control (powdered curcumin in water), leading to an appreciable increase in oral bioavailability.
The efficacy of curcumin-loaded solid lipid nanoparticles (Cur-SLNs) and nanostructured lipid
carriers (Cur-NLCs) has been compared using in vitro and in vivo studies [145]. Cur-SLNs were
prepared using cetyl palmitate as a lipid source, leading to a highly regular crystalline structure,
whereas Cur-NLCs were formulated using oleic acid and cholesterol as a lipid source, leading to a more
irregular solid structure. The storage stability, antioxidant activity, pharmacokinetics, and cytotoxicity
of the Cur-SLNs and Cur-NLCs were then compared. The entrapment efficiency and storage stability
of the Cur-NLCs were higher than that of the Cur-SLNs, but their antioxidant activities were similar.
In an animal (rat) pharmacokinetic study, the area under the curve (AUC) in the plasma was 5-fold
and 2-fold higher for Cur-NLCs and Cur-SLNs than the control, indicating that both delivery systems
increased the bioavailability. Thus, NLCs appeared to be more effective at increasing the efficacy
of curcumin than SLNs. In vivo studies with humans have shown that curcumin-loaded SLNs can
appreciably increase the bioavailability of curcumin [146].
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7.6. Biopolymer Particles
Biopolymer particles are typically assembled from proteins and/or polysaccharides using an
appropriate method. The method employed depends on the nature of the biopolymers themselves,
as well as the required characteristics of the colloidal particles formed (such as the composition, size,
shape, charge, and stability). The final particles usually contain biopolymer molecules held together
by attractive forces, such as hydrophobic, electrostatic, or hydrogen bonding interactions. The most
common methods of inducing the assembly of biopolymer molecules are ionotropic, cold-set, heat-set,
or enzymatic gelation. The most common particle-forming methods include injection, emulsion
templating, electrostatic complexation, antisolvent precipitation, and thermodynamic incompatibility
methods [147]. Biopolymer particles can be prepared with mean diameters ranging from around
100 nm to 1 mm depending on the fabrication method used.
Biopolymer particles can be formed from proteins or polysaccharides that have antioxidant
properties, thereby protecting labile nutraceuticals from chemical degradation [98]. They can also be
designed to retain nutraceuticals under one set of environmental conditions but then release them
under another set [147]. For example, biopolymer particles could be designed to retain curcumin
during storage, mouth, and stomach conditions but then release it in under small intestinal conditions.
Curcumin-loaded lipid droplets have been encapsulated within hydrogel beads made from either
alginate (370 µm) or chitosan (255 µm) using an injection-gelation method [148]. The anionic alginate
was cross-linked with cationic calcium ions, whereas the cationic chitosan was cross-linked with
anionic tripolyphosphate ions. Interestingly, encapsulating the curcumin-loaded lipid droplets within
the hydrogel beads actually reduced its chemical stability. Moreover, there was some swelling and
shape changes in the beads during storage. Curcumin has also been encapsulated within wheat protein
microgels (510 nm) formed by heating the system at a controlled pH [149]. The protein microgels had
a relatively high encapsulation efficiency (90%), good sedimentation stability, and high antioxidant
activity, which may be important for commercial applications.
Encapsulating curcumin within biopolymer microgels may be an advantage in applications where
sustained or triggered release is required. An in vitro study showed a faster and higher release of
curcumin from free oil droplets than from oil droplets trapped in either carrageenan beads or alginate
beads [150]. Similarly, the release of curcumin under simulated gastrointestinal conditions has been
shown to be reduced when it is encapsulated within whey protein microgels [149]. These results
suggest that biopolymer microgels may be useful for prolonging the release of curcumin, rather than
increasing its bioavailability.
The water dispersibility and antioxidant activity of curcumin have been increased by incorporating
it within the hydrophobic cores of casein micelles [151]. In a human study, it was shown that the
oral bioavailability of curcumin could be increased substantially by loading it into γ-cyclodextrin
complexes [152].
7.7. Nature-Derived Colloidal Particles
The growing interest in developing more sustainable and healthy food products has led many
food scientists to explore the possibility of using nature-derived colloidal particles to encapsulate
curcumin. Recently, it was shown that curcumin could be encapsulated within the milk fat globules in
bovine milk [136] and the oil bodies in plant-based milks [152]. The curcumin was loaded into these
nature-derived colloidal particles using the pH-shift method. First, curcumin is dissolved in a highly
alkaline aqueous solution (pH 12), which is then mixed with an acidified milk product. The final pH of
the mixed system is designed to be neutral or below, leading to a decrease in the water solubility of
the curcumin, which causes it to move into the hydrophobic core of the colloidal particles (milk fat
globules or oil bodies). The authors showed that the curcumin-loaded milks had good storage stability
and a high curcumin bioaccessibility, as determined by an in vitro digestion method [136,152].
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8. Conclusions
Curcumin has been used as an edible health-promoting substance for thousands of years as part of
traditional medicinal practices in Asia. More recently, modern scientific methods have demonstrated
that curcumin exhibits a broad spectrum of biological activities that may be beneficial to human health,
including antioxidant, antimicrobial, anti-inflammatory, and antitumor activities. Even so, there are
a number of challenges that have to be addressed when formulating curcumin-based functional
foods or therapeutics, including its low water solubility, chemical stability, and bioavailability. In this
article, we highlighted some of the methods that can be used to overcome these problems, including
antioxidant, encapsulation, and storage strategies. In particular, we focused on the utilization
of colloidal delivery systems, such as micelles, liposomes, microemulsions, emulsions, solid lipid
nanoparticles, biopolymer particles, and nature-derived colloidal particles. Each of these delivery
systems has its own advantages and disadvantages for specific applications and it is important to
select the most appropriate formulation. For instance, there are differences in the appearances, textures,
mouthfeels, flavors, shelf-lives, and environmental histories of different curcumin-fortified functional
food products (such as soft drinks, milky drinks, sauces, dressings, and bakery goods), which require
different kinds of encapsulation technologies. In the future, it will be important to compare different
formulations in terms of their cost, ease of manufacture, robustness, pharmacokinetics, bioavailability,
bioactivity, sustainability, and environmental impact. The most suitable formulation for a specific
application can then be selected.
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